The pharmaceutical giant with more than 240 billion yuan, the leading CXO stock, WuXi AppTec, announced on November 25 that the actual controller and the joint actors will reduce their holdings of the company's 65 million shares within six months. The share capital this time has

240 billion yuan of pharmaceutical white horses, CXO leading stock, WuXi AppTec , announced on November 25 that the actual controller and the joint actors will reduce their holdings of the company's 65 million shares of shares within six months. The share capital reduced this time reaches 2.2%, and the total amount of the reduction is expected to exceed 5 billion!

WuXi AppTec has now become an ATM for major shareholders. After the last share reduction, the stock price of hit the limit and fell sharply continuously. The stock price fell to 67.2 yuan at the lowest point. This time, less than two months after the last share reduction, the wound has not healed yet, and it is necessary to start sprinkling salt on the wound again, which makes investors bear it!

WuXi AppTec's current share price is 81.94 yuan, with a market value of 242.6 billion yuan. The highest price after re-righted is 171.97 yuan. It has fallen for more than a year, and the price has been halved at the high point. Although the company's performance has been pretty good and continues to maintain full-year growth this year, the stock price has been downward.

Many people replenish their positions, increases their positions in all the way, and have always believed in value investment, but in the end they were harvested in vain!